1. Home
  2. VRME vs LIXT Comparison

VRME vs LIXT Comparison

Compare VRME & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • LIXT
  • Stock Information
  • Founded
  • VRME 1999
  • LIXT 2005
  • Country
  • VRME United States
  • LIXT United States
  • Employees
  • VRME N/A
  • LIXT N/A
  • Industry
  • VRME EDP Services
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRME Technology
  • LIXT Health Care
  • Exchange
  • VRME Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • VRME 11.0M
  • LIXT 12.4M
  • IPO Year
  • VRME N/A
  • LIXT N/A
  • Fundamental
  • Price
  • VRME $0.82
  • LIXT $6.01
  • Analyst Decision
  • VRME Strong Buy
  • LIXT
  • Analyst Count
  • VRME 2
  • LIXT 0
  • Target Price
  • VRME $1.50
  • LIXT N/A
  • AVG Volume (30 Days)
  • VRME 150.1K
  • LIXT 165.5K
  • Earning Date
  • VRME 11-11-2025
  • LIXT 11-11-2025
  • Dividend Yield
  • VRME N/A
  • LIXT N/A
  • EPS Growth
  • VRME N/A
  • LIXT N/A
  • EPS
  • VRME N/A
  • LIXT N/A
  • Revenue
  • VRME $22,071,000.00
  • LIXT N/A
  • Revenue This Year
  • VRME N/A
  • LIXT N/A
  • Revenue Next Year
  • VRME $5.98
  • LIXT N/A
  • P/E Ratio
  • VRME N/A
  • LIXT N/A
  • Revenue Growth
  • VRME N/A
  • LIXT N/A
  • 52 Week Low
  • VRME $0.55
  • LIXT $0.64
  • 52 Week High
  • VRME $5.00
  • LIXT $6.26
  • Technical
  • Relative Strength Index (RSI)
  • VRME 43.78
  • LIXT 71.83
  • Support Level
  • VRME $0.80
  • LIXT $4.28
  • Resistance Level
  • VRME $0.94
  • LIXT $4.85
  • Average True Range (ATR)
  • VRME 0.05
  • LIXT 0.58
  • MACD
  • VRME -0.01
  • LIXT 0.17
  • Stochastic Oscillator
  • VRME 11.11
  • LIXT 91.67

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: